uniQure Announces Company Participation at Citi Healthcare Conference
August 24 2017 - 7:00AM
uniQure N.V. (NASDAQ:QURE), a leading gene therapy company
advancing transformative therapies for patients with severe medical
needs, today announced that it will participate in a gene therapy
panel discussion and host investor meetings during the Citi
Healthcare Conference held in Boston from September 5-7, 2017.
Matt Kapusta, chief executive officer of
uniQure, will participate on the analyst-moderated panel entitled,
“Gene-Therapy Manufacturing and Regulatory – Challenges and
Opportunities” on Thursday, September 7, 2017 at 11:00 am
EDT. A live webcast of the panel discussion can be accessed
through the link displayed in the Investor Section of the uniQure
website at
http://uniqure.com/investors-newsroom/events-presentations.php.
A replay of the webcast will be available within 24 hours following
the event, and will remain available for at least two weeks.
About uniQure uniQure is
delivering on the promise of gene therapy – single treatments with
potentially curative results. We are leveraging our modular and
validated technology platform to rapidly advance a pipeline of
proprietary and partnered gene therapies to treat patients with
hemophilia, Huntington’s disease and cardiovascular diseases.
www.uniQure.com
uniQure Contacts:
For Investors:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com
For Media:
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024